Skip to main content
Clinical Trials/NCT03203382
NCT03203382CompletedNot Applicable

Corneal Nerve Structure in Sjogren's

University of Pennsylvania1 site in 1 country100 target enrollmentStarted: September 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
Vitamin D Level

Study Overview

Brief Summary

Patients who are suspected of or diagnosed with Sjogren's disease will be evaluated for ocular symptoms and corneal nerve morphology. We are specifically interested in the relationship between Vitamin D level and aberrations in the morphology of the corneal nerves.

Detailed Description

Patients with either suspected or confirmed diagnosis of Sjogren's disease will be recruited to participate. Participation will involve the completion of a brief survey (the OSDI), corneal evaluation with an aesthesiometer, corneal staining with fluorescein and lissamine green, and finally measurement of tear-film breakup time. In addition, participants will have their corneal nerve morphology evaluated with the Heidelberg confocal microscope and finally they will have a blood draw performed to assess vitamin D level.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Suspected or confirmed Sjogren's syndrome
  • 18+ years of age

Exclusion Criteria

  • Any condition that in the opinion of the investigator may confound study results or cause concerns for safety

Outcomes

Primary Outcomes

Vitamin D Level

Time Frame: one time exam at baseline, day 1

serum

Corneal Nerve Morphology

Time Frame: one time exam

Heidelberg Retina Tomograph with the Rostock Cornea Module

Secondary Outcomes

  • vital dye staining(one time exam at baseline, day 1)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials